A recent study indicates that individuals who come off blockbuster weight-loss injections like Mounjaro or Wegovy may regain shed pounds at a significantly accelerated pace than those who end traditional diet and exercise programs.
Published data in a leading medical journal shows that while overweight individuals frequently drop substantial amounts of their body weight while using the jabs, the weight returns at an average rate of 0.8 kg per month once they quit.
"Users using these medications should be cognizant of the potential of rapid rebound weight gain when the medication ends," warns lead investigator Dr. Susan Jebb.
That rate of regain implies a reversion to pre-treatment weight within about a year and a half.
Comparing Approaches
The analysis, which looked at 37 of trials involving over 9,000 of patients, contrasted the results of these new drugs with older methods.
Scientists note that people who lose weight through lifestyle changes alone typically have a less rapid creep back—around 100 grams monthly—post-intervention.
Understanding the Fast Regain
Experts propose the mode of action of the drugs is key to understanding the amplified regain.
GLP-1 drugs imitate a natural hormone called GLP-1, which moderates feelings of fullness.
"Sustained high doses of the hormone concentrations several times higher than the body's typical production might result in the system to produce less of its own natural hormone, and may also reduce responsiveness to its actions," said Dr. Adam Collins, a nutrition expert.
"Withdrawal of this medication means hunger is uncontrolled, making overeating a significant risk."
A Chronic Condition?
The NHS advise the injections for people with obesity-related health risks, accompanied by recommended diet and exercise modifications.
Professionals contend that, given the significant potential of weight regain, the treatment should be considered life-long.
This perspective is echoed by pharmaceutical companies, who say that the results "emphasize the long-term nature of obesity," akin to managing conditions like hypertension.
User Testimonies
Individuals who have stopped the medication report a intense resurgence of hunger.
"It felt as if something that goes on and I was suddenly starving," said a patient.
The struggle is exacerbated if users have not developed permanent lifestyle or habit modifications during therapy.
Growing Adoption
Survey data suggest that a significant number of adults in the UK have tried these injections in the last 12 months, with demand remaining high.
- Use is greater among women than men.
- The 40s and 50s age group shows the highest usage rates.
- A large proportion obtain the medications through private healthcare rather than public health services.
In conclusion, clinicians stress that while the jabs are potent agents for shedding pounds, they are not a standalone cure and lasting health benefits hinges on ongoing behavioural management.
